Cerebral
This page reports what Cerebral publishes on its own public pages, with the date each fact was last checked. It contains no rankings, recommendations, or medical advice.
Company record
- Website
- https://cerebral.com/
- Founded
- 2020
- Provider model
- video required
- Pharmacy model
- mixed
- Accepts insurance
- yes
- Categories served
- mental health (clean)
- Legal entity
- "The Platform is owned and operated by Cerebral Inc. and/or its subsidiaries (collectively, 'Cerebral'), and the Services ... are provided by Cerebral Medical Group, P.A. (Florida), Cerebral Medical Group P.C.
Full collected entry
"The Platform is owned and operated by Cerebral Inc. and/or its subsidiaries (collectively, 'Cerebral'), and the Services ... are provided by Cerebral Medical Group, P.A. (Florida), Cerebral Medical Group P.C. (California), Cerebral Medical Group, P.C. (Alaska), Cerebral Medical Group, P.C. (Kansas), or Cerebral Medical Group, P.A. (New Jersey), Resilience Medical, P.C. (New Jersey), Resilience Psychotherapy LCSW P.C. (New York), or Resilience Medical, PC (California) (each, a 'Medical Group')." — Terms and Conditions of Use, last revised September 17, 2025. "Cerebral does not own or have any ownership interest in the Medical Groups and the Medical Groups do not own or have any ownership interest in Cerebral" (the standard "friendly PC" telehealth structure — clinical care is delivered by the separately-owned Medical Groups; the technology Platform is owned by Cerebral Inc.). Footer address: "2093 Philadelphia Pike #9898 Claymont, DE 19703." The "Resilience Medical" / "Resilience Psychotherapy" Medical Groups reflect Cerebral's August 2025 acquisition of Resilience Lab (see corporate_facts).
The entry exactly as collected from Cerebral's own public pages.
Corporate facts
Private company (no IPO found in any source checked), headquartered per footer address in Claymont, DE (registered-agent address; operations are understood to be distributed/remote). Co-founded 2020 by Kyle Robertson (CEO) and Ho Anh (Medical Director) — third-party sourced (Wikipedia, Bloomberg).
Full collected entry
Private company (no IPO found in any source checked), headquartered per footer address in Claymont, DE (registered-agent address; operations are understood to be distributed/remote). Co-founded 2020 by Kyle Robertson (CEO) and Ho Anh (Medical Director) — third-party sourced (Wikipedia, Bloomberg). Raised early funding including a reported $35M round (MobiHealthNews, Oct 2020) — third-party, not verified on cerebral.com. Current CEO per cerebral.com's own about page (about-cerebral.md) is Brian Reinken; Wikipedia separately lists David Mou as a prior CEO (installed May 2022) between Robertson's exit and Reinken. CONTROVERSY / REGULATORY HISTORY (Cerebral's own public pages are silent on all of the below; sourced from primary regulatory documents and business press): - Controlled-substance prescribing: beginning in 2022, Cerebral came under DOJ and media scrutiny for its stimulant (e.g., Adderall, Ritalin) prescribing practices for ADHD. Kyle Robertson stepped down as CEO in May 2022 amid this scrutiny (Forbes, "Kyle Robertson Is Out As CEO Of Mental Health Startup Cerebral," May 18, 2022; Fierce Healthcare). Cerebral stopped writing new controlled-substance prescriptions in 2022 and, per Behavioral Health Business (Feb 2023), later closed its medication-assisted-treatment program entirely along with a 15% staff layoff. - DOJ resolution (Nov 2024): Cerebral reached a non-prosecution agreement with the U.S. Attorney's Office for the Eastern District of New York resolving the controlled-substance-prescribing investigation, with fines totaling $6.57 million — $3.65 million in forfeited proceeds "related to revenue earned in violation of federal law related to the prescription of ADHD medications," plus a $2.92 million penalty the U.S. Attorney's office agreed to waive contingent on compliance and Cerebral's financial performance (Behavioral Health Business, "Cerebral Hit with $6.6M Penalty In Settlement with Prosecutors," Nov 5, 2024, citing the released non-prosecution agreement). U.S. Attorney Breon Peace stated Cerebral "sought to drive up profits by pushing its clinicians to prescribe ADHD medications and other controlled substances." - FTC settlement (April 2024): the FTC's proposed order (filed by DOJ) charged Cerebral and former CEO Kyle Robertson with deceiving users about data-sharing/security practices and misleading consumers about cancellation policies, in violation of the FTC Act, ROSCA (Restore Online Shoppers' Confidence Act), and OARFPA (Opioid Addiction Recovery Fraud Prevention Act of 2018). The complaint alleges Cerebral shared sensitive data — including names, medical/prescription histories, and health insurance information — for roughly 3.2 million consumers with third parties (LinkedIn, Snapchat, TikTok) via tracking tools, for advertising purposes. On cancellation specifically: "Despite promising that consumers could 'cancel anytime,' Cerebral required its clients to navigate a complex, multi-step, and often multi-day process to cancel," continued charging consumers during the delay, and — after testing an easier one-click cancel button in April 2020 and seeing cancellations rise — removed that button after two weeks "at Robertson's direction" (FTC press release, April 2024, quoting the complaint). The order requires Cerebral to pay more than $7 million (nominal order value ~$15M per Behavioral Health Business, with portions suspended/waived): approximately $5.1 million for consumer refunds (40,000+ people refunded per Fierce Healthcare) and a $10 million civil penalty suspended to a $2 million payment based on inability to pay the full amount. The order also bans Cerebral from using health information for most advertising purposes and requires a simple, easy-to-use cancellation mechanism going forward. The complaint against Robertson personally was not resolved by this order and was left to the court. Source: FTC press release "Proposed FTC Order will Prohibit Telehealth Firm Cerebral from Using or Disclosing Sensitive Data for Advertising Purposes, and Require it to Pay $7 Million" (ftc.gov, April 2024); corroborated by Fierce Healthcare. - M&A / current direction: Cerebral acquired Resilience Lab, a behavioral-health group, announced August 4, 2025 ("A New Era of Mental Healthcare," cerebral.com/blog/resilience-lab-acquisition — this is on Cerebral's own site). CEO quoted in that post is Brian Reinken. The acquisition FAQ states: "All current Cerebral pricing, features, and support will remain the same at this time" (faqs/plans-costs- insurance page). This acquisition is the source of the "Resilience Medical" / "Resilience Psychotherapy" Medical Group entities named in the current Terms and Conditions. NET ASSESSMENT: as of 2026-08-15, Cerebral operates as a going, publicly marketed direct-to-consumer (and insurance-billed) mental health platform — pricing pages, plan pages, and an active blog/FAQ are all live and current (most recent blog post dated Aug 4, 2025; ToS last revised Sept 17, 2025). It no longer prescribes any controlled substances (confirmed on current medication page: "We do not prescribe controlled substances"). It has settled (not admitted liability in the FTC matter, which remains a proposed/consent order) both the DOJ controlled-substance investigation and the FTC data-privacy/cancellation case as of late 2024, and grew via acquisition (Resilience Lab) in 2025 rather than shrinking or exiting DTC.
The entry exactly as collected from Cerebral's own public pages.
Advertised, unconfirmed Last checked Aug 15, 2026.
Published prices
Advertised price is the number the company publishes. Monthly equivalent normalizes non-monthly billing to a per-month figure. All-in monthly adds the membership fee the company's own pages state is required and billed separately. Prices last checked Aug 15, 2026.
mental health
| Treatment | Advertised | Monthly equivalent | Membership on top | All-in monthly | Includes | Last checked | |
|---|---|---|---|---|---|---|---|
| Medication + Psychiatry plan — 1-on-1 online psychiatric evaluation with a licensed prescriber (PMHNP or high… | $180 per 3 mo | $60 | none published | $60 | visit, meds, shipping, messaging | VerifiedAug 15, 2026 | |
| |||||||
| Individual Therapy plan — 60-minute video or phone sessions with a licensed therapist. | $175 per visit | none published | n/a | visit, messaging | Recheck queuedAug 15, 2026 | ||
| |||||||
| Medication + Therapy plan — combined bundle: "Includes all the features and benefits of our medication and th… | $365/mo | $365 | none published | $365 | visit, meds, shipping, messaging | Recheck queuedAug 15, 2026 | |
| |||||||
How to cancel
Quoted from Cerebral's terms and help pages on Aug 15, 2026. Only the cancellation mechanism is in our words; everything else is the company's.
How cancellation works
- Cancellation mechanism
- self serve online
- Automatic renewal
- see terms belowRenews automatically until cancelled. "Unless otherwise stated when you sign up for a Subscription, your selected Services will automatically renew for a further Subscription Period with the Subscription Fee (including any applicable taxes) and will continue to do so unless we are either no longer offering that Service ... or your Subscription has been canceled" (Terms and Conditions Section 1.2). Price-increase notice: "If the pricing for your Subscription increases, you will be notified and provided an opportunity to change or cancel your Subscription before applying those changes ... or charging you in connection with an automatic renewal."
- Cancellation terms as published
- Terms and Conditions Section 1.4 ("Cancellations and Refunds"): "You can cancel by clicking 'Cancel Subscription' in your User Account no later than the day before your next scheduled billing date to cancel your Subscription. Step-by-step cancellation instructions can be found in our FAQs." Cancellation takes effect at the end of the current Subscription Period, not immediately: "you cancel only future charges ... the cancellation will become effective at the end of your current Subscription Period." If not canceled in time, "you will be charged for the next Subscription Period and your Subscription will be canceled in the following Subscription Period." Separately, canceling a Subscription does not delete the User Account/data ("canceling a Subscription will not operate to deactivate your User Account"); full account deactivation requires contacting support@cerebral.com. REGULATORY CONTEXT (not on Cerebral's own pages; recorded per collection brief from a primary regulatory source): the FTC's April 2024 complaint alleged that, historically, "[d]espite promising that consumers could 'cancel anytime,' Cerebral required its clients to navigate a complex, multi-step, and often multi-day process to cancel," continued charging consumers during the delay, and had removed an easier one-click cancel button two weeks after launching it in April 2020 "at [then-CEO] Robertson's direction" after seeing cancellations rise (FTC press release, April 2024). The resulting consent order requires Cerebral to provide "a simple way to cancel services." The self-serve "Cancel Subscription" button described in the current (Sept 2025) Terms and Conditions and in the current FAQ ("How do I cancel my subscription?" listed as a Popular Topic) is consistent with a post-settlement, simplified mechanism, though this collection pass did not test the actual in-account cancellation flow (out of scope per public-pages-only rule).
- Refund policy as published
- Terms and Conditions Section 1.4: "All purchases are final and once paid, all fees, including Subscription Fees, are non-refundable regardless of whether Services are utilized, except as prohibited by applicable law." "Except as otherwise stated herein or required by applicable law, no refunds will be provided for a partial Subscription Period, but you will continue to have access to the Subscription until the next billing cycle." Discretionary exception: "We reserve the right to issue refunds or credits at our sole discretion. If we issue a refund or credit in one instance, we are under no obligation to issue the same refund or credit in the future." Company-initiated cancellation is treated differently: "Notwithstanding any other terms, the ... Medical Groups reserve the right to cancel your Subscription in its entirety at any time and for any reason ... If [they] exercise their right to cancel a Subscription, you will be refunded the current Subscription Period's Subscription Fee." Medication orders: "final once shipped by the Pharmacies, and the order cannot be returned or refunded," though orders "may be canceled before they are shipped."
- Trial terms as published
- No fixed-length free trial is advertised on any pricing/plan page checked. Terms and Conditions Section 1.2 ("Trials and Promotional Fees") describes the mechanism generally but does not commit to a specific duration: "We may periodically offer discounts to our Services in the form of free trial periods or promotional fees. The terms of those discounts will be stated at the time you sign up... Upon completion of your free trial, your Subscription will automatically convert into a paid Subscription... unless you have canceled." "You may only be permitted to use one free trial or promotional fee offer." The only currently-published discount mechanic found is the AFM20 code ("$20 off your first Affordable Meds cash plan," see medication offer) and the 3-month prepay discounts on Therapy ($795/3mo) and the Medication+Therapy bundle ($885/3mo) — neither is framed as a "trial."
States served
Not a single dedicated states page (the guessed /states URL does not exist). "Available in all 50 states" (about-cerebral.md summary stat) and "We've delivered integrated therapy and medication management to over half a million people across all 50 states" (about-cerebral.md).
Full collected entry
Not a single dedicated states page (the guessed /states URL does not exist). "Available in all 50 states" (about-cerebral.md summary stat) and "We've delivered integrated therapy and medication management to over half a million people across all 50 states" (about-cerebral.md). No state-level exclusions found in the pages checked. See individual offers for category-specific restatements.
The entry exactly as collected from Cerebral's own public pages.
Last checked Aug 15, 2026.
How to read this page
3 flags · 1 rule
- Verified
- We confirmed the fact on a public page.
- Advertised, unconfirmed
- Cerebral publishes the number, but we could not confirm the final checkout price without creating an account, which we do not do.
- Recheck queued
- The source page changed or would not load on the last pass, so the fact is queued for recollection.
- Every fact is dated
- Every fact here comes from Cerebral's own public pages, on the date shown next to it.